Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. latin america
  4. solid tumor
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Locations
Back to All Locations

  • Latin America
  • Antigua & Barbuda
  • Argentina
  • Aruba
  • Bahamas
  • Barbados
  • Belize
  • Bolivia
  • Brazil
  • Cayman Islands
  • Chile
  • Colombia
  • Costa Rica
  • Cuba
  • Dominica
  • Dominican Republic
  • Ecuador
  • El Salvador
  • Grenada
  • Guatemala
  • Guyana
  • Haiti
  • Honduras
  • Jamaica
  • Mexico
  • Netherlands Antilles
  • Nicaragua
  • Panama
  • Paraguay
  • Peru
  • Puerto Rico
  • St. Kitts & Nevis
  • St. Lucia
  • St. Vincent & The Grenadines
  • Suriname
  • Trinidad
  • Uruguay
  • Venezuela
Business Types

  • Manufacturer
  • Technology
  • Service provider
  • Software vendor
  • Laboratory
Industries served

  • Medical / Health Care
  • Chemical & Pharmaceuticals
  • Monitoring and Testing
  • Environmental
  • Health and Safety
Employees

  • 101-1000
  • Over 1000

Solid Tumor Suppliers Serving Latin America

105 companies found
Serving Latin AmericaNear Latin America

Sutro Biopharma Inc.

Sutro Biopharma Inc.

based inSouth San Francisco, CALIFORNIA (USA)
Sutro Biopharma is a clinical stage company pioneering a compelling and unique way of discovering, developing and manufacturing therapeutics. Our focus is aimed primarily on next-generation cancer therapeutics – antibody drug conjugates, bispecific ...
CONTACT SUPPLIER

Amoy Diagnostics Co., Ltd.

Amoy Diagnostics Co., Ltd.

based inXiamen, CHINA
Amoy Diagnostics Co., Ltd. (AmoyDx) is an R&D based diagnostic company, focusing on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS®, Super-ARMS®, ddCapture® and ADx-HANDLE® ...
CONTACT SUPPLIER

BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc.

based inNew Haven, CONNECTICUT (USA)
BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence, or AI, approaches to develop transformative medicines in neuroscience and immuno-oncology. We are focused on utilizing cutting-edge ...
BioXcel - Model BXCL701 - Immuno-Oncology Medicine

BioXcel - Model BXCL701 - Immuno-Oncology Medicine

BXCL701 (talabostat) is an investigational, oral small molecule inhibitor of dipeptidyl peptidases (DPP)—primarily DPP 8/9 and DPP 4—which triggers inflammasome to alert and prime immune cells, leading to induction of IL-18 and ...
CONTACT SUPPLIER

Immune-Onc Therapeutics, Inc.

Immune-Onc Therapeutics, Inc.

based inPalo Alto, CALIFORNIA (USA)
Immune-Onc is a clinical-stage company developing a novel class of myeloid checkpoint inhibitors. We believe myeloid checkpoints are the next frontier of immunotherapy for cancer. In collaboration with scientists, our research team is among the ...
Immune-Onc - Model IO-108 - (Anti-LILRB2) Mechanisms of Action Program

Immune-Onc - Model IO-108 - (Anti-LILRB2) Mechanisms of Action Program

Immune-Onc is evaluating IO-108, an antagonist antibody targeting the myeloid checkpoint, LILRB2 (also known as ILT4). The U.S. FDA has cleared the IND application for IO-108 as a potential therapy for solid tumors. ...
CONTACT SUPPLIER

The Menarini Group

The Menarini Group

based inFlorence, ITALY
The Menarini Group is a leading international pharmaceutical and diagnostics company, with a turnover of over $4 billion and over 17,000 employees. Menarini is focused on therapeutic areas with high unmet needs with products for cardiology, ...
Model MEN1309 - Antibody-Drug Conjugate (ADC)

Model MEN1309 - Antibody-Drug Conjugate (ADC)

MEN1309 is an antibody-drug conjugate (ADC) constituted by a fully human IgG1 antibody conjugated through a cleavable linker to a cytotoxic agent (a maytansin derivative, DM4), responsible for its antitumor activity. The target antigen, CD205, is ...
CONTACT SUPPLIER

PsiOxus Therapeutics Ltd.

PsiOxus Therapeutics Ltd.

based inAbingdon, UNITED KINGDOM
PsiOxus is a clinical-stage company redefining therapies for solid tumors with the goal of curing patients with cancer. Our clinically validated, systemically dosed T-SIGn® viral vector platform delivers tumor-localized production of combinations of ...
CONTACT SUPPLIER

Beyond Air Inc

Beyond Air Inc

based inNew York, NEW YORK (USA)
Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential ...
CONTACT SUPPLIER

Shanghai Henlius Biotech, Inc

Shanghai Henlius Biotech, Inc

based inShanghai, CHINA
Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases. Up to date, 5 ...
Henlius - Model HLX07 - Recombinant Anti-Epidermal Growth Factor Receptor (EGFR) Humanised Monoclonal Antibody Injection

Henlius - Model HLX07 - Recombinant Anti-Epidermal Growth Factor Receptor (EGFR) Humanised Monoclonal Antibody Injection

HLX07, recombinant anti-epidermal growth factor receptor (EGFR) humanised monoclonal antibody injection independently researched and developed as biobetter. It was granted IND approvals to be evaluated in clinical trials in China and the United ...
CONTACT SUPPLIER

Affimed GmbH

Affimed GmbH

based inHeidelberg, GERMANY
We are a team of passionate, experienced individuals who work every day to improve the lives of patients. Led by an expert team of biotechnology and pharmaceutical professionals, we are united by one goal—to stop cancer from ever derailing patients’ ...
Affimed - Model AFM13 - Innate Cell Engager Molecule

Affimed - Model AFM13 - Innate Cell Engager Molecule

Lighting the way with clinical results: we are creating success with monotherapies and combination therapies. AFM13, a first-in-class ICE (innate cell engager) molecule targeting patients with CD30-positive lymphomas,4 showed antitumor responses in ...
CONTACT SUPPLIER

BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc.

based inPalo Alto, CALIFORNIA (USA)
BridgeBio is committed to developing leaders as well as drugs. We are looking for individuals whose passion for creating life-changing medicines will inspire hands-on engagement and the dogged pursuit of novel solutions in the face of adversity. To ...
CONTACT SUPPLIER

Antengene Corporation Limited

Antengene Corporation Limited

based inChangning District, CHINA
Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative ...
CONTACT SUPPLIER

Thermo Fisher Scientific

Thermo Fisher Scientific

based inWaltham, MASSACHUSETTS (USA)
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are ...
CONTACT SUPPLIER

Celularity Inc.

Celularity Inc.

based inFlorham Park, NEW JERSEY (USA)
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and ...
Celularity - Model CAR-T - Chimeric Antigen Receptor T Cells

Celularity - Model CAR-T - Chimeric Antigen Receptor T Cells

Chimeric Antigen Receptor T cells (CAR-T) are genetically engineered T cells that are modified to express an artificial T cell receptor on their surface that binds and targets cancer proteins in an HLA-independent ...
CONTACT SUPPLIER

Actym Therapeutics

Actym Therapeutics

based inBerkeley, CALIFORNIA (USA)
Actym Therapeutics is a cutting-edge biotech focused on the discovery and development of novel immuno-oncology therapies. Actym is also developing a broad pipeline of additional therapeutic candidates intended to treat checkpoint refractory ...
Actym - Biotechnology Pipeline Product

Actym - Biotechnology Pipeline Product

The company has developed an attenuated, microbial-based, technology platform called STACT (S. Typhimurium-Attenuated Cancer Therapy). In preclinical studies, STACT specifically enriches in many types of solid ...
CONTACT SUPPLIER

Transgene

Transgene

based inIllkirch-Graffenstaden, FRANCE
Transgene is a clinical-stage biotechnology company focused on designing and developing novel immunotherapeutics. Every day, we push the boundaries of innovation with our therapeutic vaccines and oncolytic viruses, to design better treatments for ...
Transgene - Model TG6002 - Oncolytic Virus

Transgene - Model TG6002 - Oncolytic Virus

A new generation of multifunctional oncolytic virus, TG6002 has been designed to combine the mechanism of oncolysis (targeted destruction of the cancer cell) with the production of chemotherapy (5-FU), directly into the ...
CONTACT SUPPLIER

Creative Biolabs

Creative Biolabs

based inShirley, NEW YORK (USA)
After decades of research and accumulation, Creative Biolabs has become a leader in the discovery and manufacturing of recombinant antibodies (rAbs), providing the most reliable and qualified services to customers in academia and industry around the ...
Creative Biolabs - Model TAB-013ML (CAT#: TAB-013ML) - Anti-Human ENG Recombinant Antibody

Creative Biolabs - Model TAB-013ML (CAT#: TAB-013ML) - Anti-Human ENG Recombinant Antibody

It is a human monoclonal antibody that can be potentially used in the treatment of Hepatocellular Carcinoma, Gestational Trophoblastic Neoplasia, Choriocarcinoma, Placental Site Trophoblastic Tumor, Epithelioid Trophoblastic ...
CONTACT SUPPLIER

SystImmune Inc.

SystImmune Inc.

based inRedmond, WASHINGTON (USA)
SystImmune Inc. is a biopharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and multi-specific antibodies, as well as antibody-drug conjugates (ADCs). Our objective is to create biologics that ...
SystImmune - Model GNC-039 - Guidance and Navigation Control (GNC) Molecules

SystImmune - Model GNC-039 - Guidance and Navigation Control (GNC) Molecules

Guidance and Navigation Control (GNC) molecules are multi-specific cell engager proteins. GNC in the oncology therapeutics class bind to cancer cells and to immune cells and stimulate the immune cell cancer killing activity. By design, each GNC ...
CONTACT SUPPLIER

Adaptimmune LLC

Adaptimmune LLC

based inPhiladelphia, PENNSYLVANIA (USA)
Adaptimmune, a leader in T-cell therapy, has clinical trials ongoing for three wholly owned SPEAR T-cells (ADP-A2M4, ADP-A2M4CD8, and ADP-A2AFP) in multiple solid tumor indications. The Company's unique SPEAR (Specific Peptide Enhanced Affinity ...
Adaptimmune - Model ADP-A2M10 (MAGE-A10) - T-Cell Therapy Pipeline

Adaptimmune - Model ADP-A2M10 (MAGE-A10) - T-Cell Therapy Pipeline

Our ADP-A2M10 (MAGE-A10) T-cell therapy is directed to a member of the MAGE family of cancer testis antigens expressed in a number of solid tumor cell types. Any expression in cancer is often associated with higher ...
CONTACT SUPPLIER

T-Cure BioScience, Inc.

T-Cure BioScience, Inc.

based inSherman Oaks, CALIFORNIA (USA)
T-Cure is a clinical-stage immuno-oncology company developing the next generation of T cell therapies for patients with solid tumors. It is committed to bringing new targets and therapies to the T-Cell Receptor (TCR) field that have a high ...
T-Cure - Model 800TCR - Human Endogenous Retro-Virus (HERV)

T-Cure - Model 800TCR - Human Endogenous Retro-Virus (HERV)

The HERV-E target is one of the quiescent Human Endogenous Retro-Virus (HERV) sequences that are turned on during tumor development. Its expression in renal cell carcinoma (RCC) is highly selective, with no transcripts detected in ...
CONTACT SUPPLIER

ORYX GmbH & Co. KG

ORYX GmbH & Co. KG

based inBaldham, GERMANY
ORYX’ development strategy bridges the gap between academic research and the pharmaceutical industry for new cancer therapies. Today, the company is developing three clinical cancer immunotherapy projects in indications with high unmet medical need. ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT